Indocyanine green

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Summary

Indocyanine green is a diagnostic agent for vascular imagine and radiography of the eye, as well as liver function tests.

Generic Name
Indocyanine green
DrugBank Accession Number
DB16024
Background

Not Available

Type
Small Molecule
Groups
Approved, Experimental
Structure
Weight
Average: 774.97
Monoisotopic: 774.27732387
Chemical Formula
C43H47N2NaO6S2
Synonyms
  • Indocyanine green
External IDs
  • 222-751-5

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
IC-GreenPowder25 mg / vialIntravenousAkorn Inc1994-12-312021-03-01Canada flag
Indocyanine Green for Injection KitKit; Powder, for solution25 mg / vialIntravenousDiagnostic Green GmbH2019-06-11Not applicableCanada flag
Indocyanine Green for Injection KitKit; Powder, for solution25 mg / vialIntravenousDiagnostic Green GmbHNot applicableNot applicableCanada flag
Indocyanine Green for Injection, USPPowder, for solution25 mg / vialIntravenousDiagnostic Green GmbH2019-06-11Not applicableCanada flag
Spy Agent GreenPowder, for solution25 mg / vialInterstitial; IntravenousNovadaq Technologies Ulc2019-06-04Not applicableCanada flag
Spy Agent Green Kit for Advanced Imaging Modality (aim) and PinpointKit; Powder, for solution25 mg / vialInterstitial; IntravenousNovadaq Technologies Ulc2023-02-15Not applicableCanada flag
Spy Agent Green Kit for Advanced Imaging Modality (aim) and PinpointKit; Powder, for solution25 mg / vialInterstitial; IntravenousNovadaq Technologies Ulc2019-06-04Not applicableCanada flag
Spy Agent Green Kit for Spy EliteKit; Powder, for solution25 mg / vialInterstitial; IntravenousNovadaq Technologies Ulc2019-06-04Not applicableCanada flag
Spy Agent Green Kit for Spy-phiKit; Powder, for solution25 mg / vialInterstitial; IntravenousNovadaq Technologies Ulc2020-12-03Not applicableCanada flag
Spy Agent Green Lymphatics Kit for Advanced Imaging Modality (aim) and PinpointKit; Powder, for solution25 mg / vialInterstitial; IntravenousNovadaq Technologies Ulc2019-06-04Not applicableCanada flag

Categories

ATC Codes
V04CX01 — Indocyanine green
Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as naphthalenes. These are compounds containing a naphthalene moiety, which consists of two fused benzene rings.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Naphthalenes
Sub Class
Not Available
Direct Parent
Naphthalenes
Alternative Parents
3-alkylindoles / Tertiary alkylarylamines / Sulfonyls / Organosulfonic acids / Alkanesulfonic acids / Propargyl-type 1,3-dipolar organic compounds / Enamines / Azacyclic compounds / Organopnictogen compounds / Organic zwitterions
show 3 more
Substituents
3-alkylindole / Alkanesulfonic acid / Amine / Aromatic heteropolycyclic compound / Azacycle / Enamine / Hydrocarbon derivative / Indole or derivatives / Naphthalene / Organic 1,3-dipolar compound
show 18 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
cyanine dye, 1,1-diunsubstituted alkanesulfonate, benzoindole (CHEBI:31696)
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
3599-32-4
InChI Key
MOFVSTNWEDAEEK-UHFFFAOYSA-M
InChI
InChI=1S/C43H48N2O6S2.Na/c1-42(2)38(44(28-14-16-30-52(46,47)48)36-26-24-32-18-10-12-20-34(32)40(36)42)22-8-6-5-7-9-23-39-43(3,4)41-35-21-13-11-19-33(35)25-27-37(41)45(39)29-15-17-31-53(49,50)51;/h5-13,18-27H,14-17,28-31H2,1-4H3,(H-,46,47,48,49,50,51);/q;+1/p-1
IUPAC Name
sodium 2-[(1E,3E,5E)-7-[(2E)-1,1-dimethyl-3-(4-sulfonatobutyl)-1H,2H,3H-benzo[e]indol-2-ylidene]hepta-1,3,5-trien-1-yl]-1,1-dimethyl-3-(4-sulfonatobutyl)-1H-benzo[e]indol-3-ium
SMILES
[Na+].CC1(C)\C(=C/C=C/C=C/C=C/C2=[N+](CCCCS([O-])(=O)=O)C3=CC=C4C=CC=CC4=C3C2(C)C)N(CCCCS([O-])(=O)=O)C2=CC=C3C=CC=CC3=C12

References

General References
  1. FDA Thailand: Diagnogreen (Indocyanine Green) Injection [Link]
ChemSpider
18108
RxNav
5775
ChEMBL
CHEMBL1646
Wikipedia
Indocyanine_green

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedDiagnosticCirrhosis of the Liver1
4CompletedOtherGraves' Disease / Thyroid Cancer / Thyroid Goiter1
4Enrolling by InvitationDiagnosticLymphedema1
4Not Yet RecruitingDiagnosticGastric Cancer1
4Not Yet RecruitingPreventionAcute Cholecystitis / Bile Duct Injury1
4RecruitingDiagnosticGastric Cancer1
4RecruitingTreatmentCubital Tunnel Syndrome1
4RecruitingTreatmentLaparoscopic Cholecystectomy1
4RecruitingTreatmentLymph Node Metastases / Prostate Cancer1
4RecruitingTreatmentMetastatic Bone Sarcomas / Metastatic Ewing Sarcoma / Non-Rhabdo. Soft Tissue Sarcoma / Pediatric Renal Tumor / Pulmonary Metastasis / Rhabdomyosarcomas1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
PowderIntravenous25 mg / vial
Kit; powder, for solutionIntravenous25 mg / vial
Powder, for solutionIntravenous25 mg / vial
Powder, for solutionInterstitial; Intravenous25 mg / vial
Kit; powder, for solutionInterstitial; Intravenous25 mg / vial
PowderIntravenous25 mg/1vial
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility4.42e-06 mg/mLALOGPS
logP4.17ALOGPS
logP6.05Chemaxon
logS-8.3ALOGPS
pKa (Strongest Acidic)-0.94Chemaxon
pKa (Strongest Basic)2.66Chemaxon
Physiological Charge-1Chemaxon
Hydrogen Acceptor Count7Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area120.65 Å2Chemaxon
Rotatable Bond Count14Chemaxon
Refractivity228.88 m3·mol-1Chemaxon
Polarizability86.31 Å3Chemaxon
Number of Rings6Chemaxon
Bioavailability0Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available

Drug created at December 14, 2020 18:13 / Updated at June 06, 2023 09:54